Clinical Trials Logo
  1. Home
  2. Subjective Tinnitus
  3. NCT04829214

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Subjective Tinnitus Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Unilateral Subjective Tinnitus

Clinical Trial Summary

The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04829214
Study type Interventional
Source Otonomy, Inc.
Contact
Status Completed
Phase Phase 2
Start date March 22, 2021
Completion date June 30, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT00955799 - Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT00739635 - Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT03550430 - Neurofeedback for Tinnitus - Does Frequency Specificity Matter? N/A
Completed NCT00772980 - Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus Phase 3
Completed NCT01268449 - Evaluation of Low Dose Laser in Treatment of Tinnitus Phase 2
Completed NCT01177137 - Tinnitus Retraining Therapy Trial Phase 3
Terminated NCT00827008 - Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT00567892 - Collaborative Tinnitus Research at Washington University Phase 2
Unknown status NCT00555776 - Effect of Gabapentin on Idiopathic Subjective Tinnitus Phase 2
Completed NCT05265949 - The Effects of Weight Loss on Tinnitus Symptoms N/A
Completed NCT04696588 - Neck Kinesiotherapy and Massage in Tinnitus Treatment N/A